Navigation Links
Fully dissolvable, temporary stent for opening heart artery blockages
Date:9/17/2013

The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages. The randomized trial aims to compare the efficiency and safety of Absorb Bioresorbable Vascular Scaffolds (Absorb BVS) in coronary artery disease patients and compare it to the current standard of care drug eluting metal stents.

Absorb BVS is a flexible artery support tube made of a naturally dissolvable material called polylactide. It is inserted by interventional cardiologists minimally invasively during a cardiac catheterization procedure. Absorb BVS works to line the interior of a blocked heart artery to keep it open and restore proper blood flow to the heart. The supportive tube then dissolves into the artery wall within two years.

"Dissolvable stents may be a future game-changer for the way we treat coronary artery disease and heart attack in the United States if proven to show clinical benefit in this nationwide clinical trial," says Samin K. Sharma, MD, Director of Clinical and Interventional Cardiology at The Mount Sinai Medical Center and the Zena and Michael A. Wiener Professor of Medicine at Icahn School of Medicine at Mount Sinai. "The stent is designed to open a blocked heart vessel and eventually dissolve and disappear, leaving no remnants on the heart of a cardiac interventional procedure."

"We look forward to testing this innovative absorbable artery support technology's efficiency and safety at Mount Sinai," says Annapoorna S. Kini, MD, Director of the Cardiac Catheterization Laboratory at The Mount Sinai Medical Center. "Since the stent is designed to completely dissolve into the arterial tissue it may potentially help improve the overall health of a patient's once blocked heart vessel while restoring its natural flexibility and movement."

"Heart disease is still the numb
'/>"/>

Contact: Lauren Woods
lauren.woods@mountsinai.org
212-241-2836
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. How to learn successfully even under stress
2. New beautifully colored long-horned beetle from Yunnan, China
3. Chinese scientists successfully crack the genome of diploid cotton
4. Efforts to develop new drugs that hopefully will never be used
5. Scale-up of a temporary bioartificial liver support system described in BioResearch Open Access
6. Temporary storage for electrons: Natural method of producing hydrogen
7. New compound excels at killing persistent and drug-resistant tuberculosis
8. Stenting dramatically improves treatment access for dialysis patients
9. Drug-coated stents prevent leg amputation
10. Stenting blocked bowel arteries saves lives
11. Global nitrogen availability consistent for past 500 years, linked to carbon levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM ... NXT-ID introduces a new revolutionary method and system ... use of miniature antenna modules for multiple purposes ...
(Date:4/2/2015)... At its 2015 ACMG Annual Clinical Genetics ... the American College of Medical Genetics and Genomics (ACMG) ... Board.  Members of the ACMG Board of Directors serve ... advancing its policies and programs. ACMG is the national ... an eventful time in medical genetics and genomics.  We ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... its touch fingerprint sensor FPC1025 from the distributor World ... will commence during Q2 2015 although the major part ... The sensors will be used by smartphone manufacturers in ... 110 MSEK is included in the communicated revenue guidance ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... Ripan Malhi looks to DNA to tell the story ... happened to them once they were here. He will share ... First Three Decades ," at The Royal Society in London on ... Institute for Genomic Biology at Illinois , will describe his collaborative ...
... has discovered a gene associated with a high risk ... be an actual cause of this form of asthma, ... "Because asthma is a complex disease, with multiple interacting ... occurring between ages two and six," said co-lead author ...
... Earth system was recovering from perhaps the single-most profound modification ... oceans. This led to a series of major changes ... of the Norwegian Geological Survey NGU reports in the latest ... in the distribution of one of life,s key elements, phosphorous. ...
Cached Biology News:Ancient, modern DNA tell story of first humans in the Americas 2Novel gene variant found in severe childhood asthma 2
(Date:5/5/2015)... AVIV, Israel , May 5, 2015 /PRNewswire/ ... the Company was approved to continue trading on ... OTCQB Marketplace allows for a ... electronic broker-dealers. Investors can have real-time quotes and ... The OTCQB Marketplace includes U.S. ...
(Date:5/5/2015)... , May 5, 2015 ImmunoCellular ... Andrew Gengos , President and Chief Executive ... 7, 2015. DATE:  Thursday, May 7, 2015     ... http://VirtualInvestorConferences.com > click the red "register/ ... a live, interactive online event where investors are ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Clinical Laboratory, Molecular Diagnostics ... 2015 to 2019 - Global Version" report ... especially in the area of molecular diagnostics and ... and evolving world market that is moving out ...
(Date:5/5/2015)... DIEGO , May 5, 2015   ... announced that David R. Parkinson , M.D., ... has been appointed to the board of directors ... years of experience in oncology clinical development, including ... resulted in global approvals of the cancer therapeutics ...
Breaking Biology Technology:Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... GmbH and BASF developed pro-t-action(TM) product based on probiotic ... oral careFull research studies introduced at International Association of ... FL , April 1-4 LUDWIGSHAFEN, Germany and ... remedy a main cause of tooth decay affecting an ...
... Board: SNKTY), a Life Sciences company engaged in the ... today announced plans for the creation of a new communication ... updated on key events. Bi-weekly updates will be recorded on ... and running in early May. In addition, callers will be ...
... Neuroscience paper describes role of Zinc in developing Alzheimer,s ... PRAN ) today announced that an independent ... California, Irvine , validates Prana,s fundamental drug strategy for ... and brain metals, such as zinc, that damages synapses ...
Cached Biology Technology:BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 2BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 3BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 4BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 5Senetek PLC Announces New Investor Communication Hotline 2Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients. 2Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients. 3Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients. 4
Mouse monoclonal antibody to ANAPC2 - anaphase promoting complex subunit 2...
... The MAX POWER 500V Programmable ... operate instruments which can handle virtually ... to high current blotting. It is ... text displays. The MAX POWER Programmable ...
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
...
Biology Products: